Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Clinical Immunology (Orlando, Fla.)|September 24, 2004
Efalizumab (anti-CD11a)-induced increase in peripheral blood leukocytes in psoriasis patients is preferentially mediated by altered trafficking of memory CD8+ T cells into lesional skinYulia Vugmeyster, Toyoko Kikuchi, Michelle A Lowes, et al.JMIR Formative Research|August 22, 2025
Design and Evaluation of a Digital Health App (SingaporeWALK) for Active Aging: Pre-Post Intervention StudyHuanyu Bao, Sowmiya Meena Siva Subramanian, Sai Ganesh Sarvotham Pai, et al.Obesity Surgery|April 28, 2023
Diabetes Mellitus Remission in Patients with BMI > 50 kg/m2 after Bariatric Surgeries: A Real-World Multi-Centered StudyWissam Ghusn, Kayla Ikemiya, Karim Al Annan, et al.Journal of Translational Medicine|June 9, 2007
Alefacept (anti-CD2) causes a selective reduction in circulating effector memory T cells (Tem) and relative preservation of central memory T cells (Tcm) in psoriasisFrancesca Chamian, Shao-Lee Lin, Edmund Lee, et al.Proceedings of the National Academy of Sciences of the United States of America|January 27, 2005
Alefacept reduces infiltrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgarisFrancesca Chamian, Michelle A Lowes, Shao-Lee Lin, et al.The Journal of Investigative Dermatology|February 2, 2008
Blockade of CD11a by efalizumab in psoriasis patients induces a unique state of T-cell hyporesponsivenessEmma Guttman-Yassky, Yulia Vugmeyster, Michelle A Lowes, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2014
Preclinical optimization of MDM2 antagonist scheduling for cancer treatment by using a model-based approachBrian Higgins, Kelli Glenn, Antje Walz, et al.Cancer Research|February 13, 2013
MDM2 small-molecule antagonist RG7112 activates p53 signaling and regresses human tumors in preclinical cancer modelsChristian Tovar, Bradford Graves, Kathryn Packman, et al.Pageof 3